The disclosure includes hydroxamic compounds of Formula I: (I) wherein P, Z, and m are defined herein. Also disclosed is a method for treating a neoplastic disease or an immune disease with these compounds.
Kofoed, Thomas; Ismail, Abd El-Hamid Aa; Pedersen, Erik B., Bulletin de la Societe Chimique de France, 1997, vol. 134, # 1, p. 59 - 66
作者:Kofoed, Thomas、Ismail, Abd El-Hamid Aa、Pedersen, Erik B.、Nielsen, Claus